نتایج جستجو برای: brca2 gene

تعداد نتایج: 1143259  

Journal: :Cancer research 1996
U Hamann C Herbold S Costa E F Solomayer M Kaufmann G Bastert H U Ulmer H Frenzel D Komitowski

Recently, the breast cancer susceptibility gene BRCA2 has been identified in chromosome 13q, a region that also contains the retinoblastoma gene RB1. To elucidate a possible role of BRCA2 and RB1 in sporadic breast tumorigenesis, allelic imbalance (AI) at 13q loci was examined in 78 primary sporadic breast tumors. AI was found in 52-63% of tumors. Nine tumors showed AI only in the BRCA2 region ...

Journal: :Cancer research 2004
Isabelle Tournier Brigitte Bressac-de Paillerets Hagay Sobol Dominique Stoppa-Lyonnet Rosette Lidereau Michel Barrois Sylvie Mazoyer Florence Coulet Agnès Hardouin Agnès Chompret Alain Lortholary Pierre Chappuis Violaine Bourdon Valérie Bonadona Christine Maugard Brigitte Gilbert Catherine Nogues Thierry Frébourg Mario Tosi

Although screening for large deletions or duplications of the BRCA1 gene is becoming a routine component of the molecular diagnosis of familial breast cancer, little is known about the occurrence of such rearrangements in the BRCA2 gene. Because of the high frequency of BRCA2 mutations in breast cancer families with at least one case of male breast cancer, we selected a cohort of 39 such famili...

Journal: :The Journal of veterinary medical science 2003
Toshina Oonuma Masami Morimatsu Kazuhiko Ochiai Bunei Syuto

Mammary tumors are common in cats. As mutations in human Brca2 confer an increased risk of breast cancer, the full-length cDNA of the feline homologue of Brca2 was sequenced to obtain a basis for studying the relationship between its function and susceptibility to mammary tumors. The feline Brca2 cDNA is 10 kb long, and encodes 3,371 amino acids. The amino acid sequence of feline Brca2 shares l...

2012
Audrey Rouault Guillaume Banneau Gaëtan MacGrogan Natalie Jones Nabila Elarouci Emmanuelle Barouk-Simonet Laurence Venat Isabelle Coupier Eric Letouzé Aurélien de Reyniès Françoise Bonnet Richard Iggo Nicolas Sévenet Michel Longy

INTRODUCTION Germline BRCA1 or BRCA2 mutations account for 20-30% of familial clustering of breast cancer. The main indication for BRCA2 screening is currently the family history but the yield of mutations identified in patients selected this way is low. METHODS To develop more efficient approaches to screening we have compared the gene expression and genomic profiles of BRCA2-mutant breast t...

Journal: :Journal of the National Cancer Institute 1998
D W Abbott M L Freeman J T Holt

BACKGROUND The protein product of the BRCA2 gene mediates repair of double-strand breaks in DNA. Because a number of cancer therapies exert cytotoxic effects via the initiation of double-strand breaks, cancers comprised of cells carrying BRCA2 gene mutations may be more amenable to treatment with agents that cause such breaks. METHODS We identified a human pancreatic adenocarcinoma cell line ...

Journal: :Journal of cell science 2010
Sergey Lekomtsev Julien Guizetti Andrei Pozniakovsky Daniel W Gerlich Mark Petronczki

Germline mutations in the tumor-suppressor gene BRCA2 predispose to breast and ovarian cancer. BRCA2 plays a well-established role in maintaining genome stability by regulating homologous recombination. BRCA2 has more recently been implicated in cytokinesis, the final step of cell division, but the molecular basis for this remains unknown. We have used time-lapse microscopy, recently developed ...

Journal: :Journal of medical genetics 2001
R B van der Luijt P H van Zon R P Jansen C J van der Sijs-Bos C C Wárlám-Rodenhuis M G Ausems

Germline mutations in either of the two major breast cancer predisposition genes, BRCA1 and BRCA2, account for a significant proportion of hereditary breast/ovarian cancer. Identification of breast cancer patients carrying mutations of these genes is primarily based on a positive family history of breast/ovarian cancer or early onset of the disease or both. In the course of mutation screening o...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2002
Nan Hu Guang Li Wen-Jun Li Chaoyu Wang Alisa M Goldstein Ze-Zhong Tang Mark J Roth Sanford M Dawsey Jing Huang Quan-Hong Wang Ti Ding Carol Giffen Philip R Taylor Michael R Emmert-Buck

PURPOSE Previous studies have shown a high rate of allelic loss in esophageal squamous cell carcinoma (ESCC) in the vicinity of the BRCA2 gene. We aimed to assess whether the tumor suppressor gene BRCA2 was the inactivation target for allelic loss observed on chromosome 13q in ESCC. EXPERIMENTAL DESIGN We examined the entire coding sequence of the BRCA2 gene for mutations using single-strand ...

2017
Glenn M. Manthey Alissa D. Clear Lauren C. Liddell Maria C. Negritto Adam M. Bailis

RAD52 is a homologous recombination (HR) protein that is conserved from bacteriophage to humans. Simultaneously attenuating expression of both the RAD52 gene, and the HR and tumor suppressor gene, BRCA2, in human cells synergistically reduces HR - indicating that RAD52 and BRCA2 control independent mechanisms of HR. We have expressed the human RAD52 gene (HsRAD52) in budding yeast strains lacki...

1998
Simon A. Gayther Bruce A. J. Ponder

The breast cancer susceptibility gene BRCA2 was isolated in 1995. BRCA2 is a large gene comprising 10,254 nucleotides and 26 coding exons. Neither the nucleotide nor the predicted protein sequences (comprising 3,418 amino acids) have provided substantial clues about its function. As a result, researchers have been trying to elucidate the function using a combination of cell biological and bioch...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید